MKI67 and breast cancer: However, an assessment of cellular proliferation by evaluating Ki-67 expression is not recommended in routine pathological evaluation by either North American Breast Cancer Group and International Ki-67 in Breast Cancer Working Group of the Breast International Group or the ASCO since it is incompletely understood how Ki-67 measurements and thresholds can influence clinical decisions [66].